Acta Medica Iranica 2018. 56(3):176-180.

Growth and Development Status in the First Two Years of Uninfected Children Born From HIV Positive Mothers
Hosein Dalili, Yasamin Mohamadzadeh, Farnoush Davoudi, Zahra Farahani, Mehrnaz Rassolinejad, Mamak Shariat, Amirali Ghahramani


Recently prevention of HIV transmission from mother to child by antiretroviral regimens has resulted in growing the numbers of HIV exposed but uninfected children (HIV-EU). The aim of present study was evaluation of growth and neurodevelopment status among less than 2-year-old HIV exposed uninfected children. A cohort study was carried out at Vali-e-Asr Hospital (Tehran-Iran). Thirty-nine HIV-EU neonates were recruited (2014 to 2016). Neonates and infants with concern to growth and neurodevelopment status were evaluated at 6, 12, 18, and 24 months by an expert physician. Neurodevelopment assessment was based on WHO Milestones Chart and Age and Stage Questionnaire. Of all children, 22 were male, and 17 were female. Regarding growth indices, although mean birth weight in half of the neonates was lower than normal population; no postnatal descending trend was observed in their growth chart. No significant differences were found between two groups' height and head circumference. Among the neurodevelopmental parameters measured, in 6th months of life, 2 cases had abnormality in the gross motor while at 12 months, 6 cases had delay in language, social problem, and motor disorders. At 18 and 24 months, 7 infants showed developmental problems of which 71.4% of their mothers were younger than others (age<25 years, P=0.009). Prevalence of neurodevelopmental disorders including delay in language, motor, and social domains was common among HIV-EU children. As several environmental factors may involve the etiology of neurodevelopmental disorders, nearly-full postnatal control and prevention seem necessary.


HIV seronegativity; Infant; Growth; Development

Full Text:



Okoko N, Owuor KO, Kulzer JL , Owino GP, Ogolla IA, Wandera R, et al. Factors associated with mother to child transmission of HIV despite overall low transmission rates in HIV-exposed infants in rural Kenya. International Journal of STD & AIDS 2017:1-9

Kuona P, Kandawasvika G, Gumbo F, Nathoo K, Pedersen B. Growth and Development of the HIV Exposed Uninfected Children below 5 Years in Developing Countries: Focus on Nutritional Challenges, Mortality and Neurocognitive Function. Food and Nutrition Sciences 2014. 5, 2000-2007.

Briand N, Mandelbrot L, Le Chenadec Jerome, et al. No relationship between in-utero exposure toHAART and intrauterine growth retardation. AIDS 2009;23:1235–1243. [PubMed: 19424054]

Townsend CL, Cortina-Borja M, Peckham CS, et al. Antiretroviral therapy and premature deliveryin diagnosed HIV-infected women in the United Kingdom and Ireland. AIDS 2007;21:1019–1026.[PubMed: 17457096]

Ekouevi DK, Coffee P, Becquet R, et al. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Cote d’Ivoire. AIDS 2008;22:1815–1820.[PubMed:18753864]

Kelly MS, Wirth KE, Steenhoff AP, Cunningham CK, Mills TA, Boiditswe SC, et al. Treatment Failures and Excess Mortality Among HIV-Exposed, Uninfected Children With Pneumonia. Journal of the Pediatric Infectious Diseases Society 2015; 4(4):117-26. DOI:10.1093/jpids/piu092

Thorne C, Newell ML. Safety of agents used to prevent mother-to-child transmission of HIV: is there any cause for concern? Drug Saf. 2007;30(30):203–213. [PubMed]

European Collaborative Study. Exposure to antiretroviral therapy in utero or early life: the health of uninfected children born to HIV-infected women. J Acquir Immune DeficSyndr 2003;32(4):380–387. [PubMed]

Chase C, Ware J, Hittelman J, Blasini I, et al. Early cognitive and motor development among infants born to women infected with human immunodeficiency virus. Women and Infants Transmission Study Group. Pediatrics 2000;106(2) Available at: [PubMed]

Paige L. Williams, Miguel Marino, Kathleen Malee, Susan Brogly, Michael D. Hughes, Lynne M. Mofenson, Neurodevelopment and In Utero Antiretroviral Exposure of HIV-Exposed Uninfected Infants. Pediatrics. 2010 Feb; 125(2): e250–e260.

Christofides NJ, Jewkes RK, Dunkle KL, Nduna M, Jama N, Sterk C. Early adolescent pregnancy increases risk of incident HIV infection in the Eastern Cape, South Africa: a longitudinal study. urnal of the International AIDS Society 2014, 17:18585

Filteau S. The HIV-exposed, uninfected African child.Trop Med Int Health 2009;14(3):276-87.

Businge CB, Longo-Mbenza B. Mathews V. Risk factors for incident HIV infection among antenatal mothers in rural Eastern Cape, South Africa. Glob Health Action 2016. 9: 29060

Sugandhi N, Rodrigues J, Kim M, Ahmed S,Amzel A, Tolle M, et al. HIV Exposed Infants: Rethinking care for a lifelong condition. AIDS 2013 Nov; 27(0 2): S187–S195.

Powis KM, Smeaton L, Ogwu A, Lockman S, Dryden-Peterson S, van Widenfelt E, et al. Effects of in utero antiretroviral exposure on longitudinal growth of HIV-exposed uninfected infants in Botswana. J Acquir Immune DeficSyndr 2011;56(2):131-8.

Agostoni C, Zuccotti G, Giovannini M, Decarlis S, Giannì ML, Piacentini E, et al. Growth in the first two years of uninfected children born to HIV-1 seropositive mothe Arch Dis Child 1998;79:175–178

Morden E, Technau K, Giddy G, Maxwell N, Keiser O, Davies M. Growth of HIV-Exposed Uninfected Infants in the First 6 Months of Life in South Africa: The IeDEA-SA Collaboration PLoS One 2016; 11(4): e0151762.

Puthanakit T, Ananworanich J, Vonthanak S, Kosalaraksa P, Hansudewechakul R, van der LugtJ,Ruxrungtham K. Cognitive function and neurodevelopmental outcomes in HIV-infected childrenolder than 1 year of age randomized to early versus deferred anti-retroviral therapy: The PREDICTneurodevelopmental study. The Pediatric Infectious Disease Journal 2013; 32:501–508.10.1097/INF.0b013e31827fb19d [PubMed: 23263176]

Malee KM, Mellins CA, Huo Y, Tassiopoulos K, Smith R, Sirois PA. Prevalence, incidence, and persistence of psychiatric and substance use disorders among mothers living with HIV.J Acquir Immune DeficSyndr 2014 Apr 15;65(5):526-34. doi: 10.1097/QAI.0000000000000070

Kartik KV, Mark NL, Elizabeth WT, Guy DB, Harwell J. Growth of infants born to HIV-infected women in South Africaaccording to maternal and infant characteristics Tropical Medicine and International Health. 2010; 15 (11) 1364–1374

Kerr SJ, Puthanakita TK, Ung V, Aurpibule L, Vonthanakf S, Kosalaraksag P, Neurodevelopmental outcomes in HIV-exposed-uninfected children versus those not exposed to HIV. AIDS Care 2014 November; 26(11): 1327–1335. doi:10.1080/09540121.2014.920949.

Chase C, Ware J, Hittelman J, Blasini I, Smith R, Llorente A. Early Cognitive and Motor Development Among Infants Born to Women Infected With Human Immunodeficiency Virus. Pediatrics 2000;106(2).

Williams PL, Hazra R, Van Dyke RB, Yildirim C, Crain MJ, Seage GR. Antiretroviral exposure during pregnancy and adverse outcomes in HIV-exposed uninfected infants and children using a trigger-based design. AIDS 2016 Jan 2;30(1):133-44. doi: 10.1097/QAD.0000000000000916

Knight W, Mellins C, Levenson R, Arpadi S, Kairam R, Effects of Pediatric HIV Infection on Mental and Psychomotor DevelopmentJ. Pediatr. Psychol. (2000) 25 (8):583-587

Van Rie A, Mupuala A, Dow A. Impact of the HIV ⁄ AIDS epidemic on the neurodevelopment of preschool-aged children in Kinshasa, Democratic Republic of Congo. Pediatrics 2008;122, e123–e128


  • There are currently no refbacks.

Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.